Read More 5 minute read Pharma Industry News Crinetics Pharmaceuticals shares soar after FDA clears Palsonify, the first oral acromegaly treatment Crinetics shares surged after FDA approval of Palsonify, the first oral acromegaly therapy. Learn how this launch reshapes patient care and investor sentiment. byPallavi MadhirajuSeptember 28, 2025